http://www.materiamed.com/info.php?rid=112 Largely owing to the success of antibody-based medicines, the company is experiencing extraordinary growth: it was able to double its sales in 2003 compared to 2002. Materia Medica believes it can continue to enjoy
sustainable growth due to further recognition of existing antibody-based medicines and introduction of new successful products new ...